Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma

被引:32
|
作者
Roma, Andres A. [1 ]
Rybicki, Lisa A. [2 ]
Barbuto, Denise [3 ]
Euscher, Elizabeth [4 ]
Djordjevic, Bojana [5 ]
Frauenhoffer, Elizabeth [6 ]
Kim, Insun [7 ]
Hong, Sung Ran [8 ]
Montiel, Delia [9 ]
Ali-Fehmi, Rouba [10 ]
Malpica, Anais [4 ]
Silva, Elvio G. [3 ]
机构
[1] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, Dept ofPathol, Cleveland, OH 44195 USA
[2] Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA
[4] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA USA
[5] Univ Ottawa, Dept Pathol, Ottawa, ON K1H 8M5, Canada
[6] Penn State Univ, Dept Pathol & Lab Med, Hershey, PA 17033 USA
[7] Korea Univ, Anam Hosp, Dept Pathol, Seoul 136705, South Korea
[8] Dankook Univ, Cheil Gen Hosp, Dept Pathol, Seoul 100450, South Korea
[9] Inst Nacl Cancerol, Mexico City 14080, DF, Mexico
[10] Wayne State Univ, Dept Pathol, Detroit, MI 48101 USA
关键词
Low-grade; Endometrial adenocarcinoma; Endometrioid; Myometrial invasion; Lymph node metastasis; Recurrence; GYNECOLOGIC-ONCOLOGY-GROUP; MELF PATTERN INVASION; STAGE-I; RANDOMIZED-TRIAL; CANCER; CARCINOMA; SURVIVAL; THERAPY; PREDICTORS; FAILURE;
D O I
10.1016/j.humpath.2015.06.015
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prognosis of endometrial adenocarcinoma is favorable; however, the risk of recurrence ranges from 7% to 13%. Recurrence has been related to age, tumor type, International Federation of Gynecology and Obstetrics grade, depth of invasion, and lymphovascular invasion (LVI); however, morphologic features that would predict the site of recurrence have not been established. In this multi-institutional study, we reviewed 589 patients with International Federation of Gynecology and Obstetrics grades 1 or 2 endometrial adenocarcinoma, endometrioid type. Cox proportional hazard analysis was used to identify univariate and multivariate risk factors for recurrence and survival. Univariate analysis revealed features of tumors that recurred only in the vagina: low nuclear grade; superficial myoinvasion; minimal to no LVI; and minimal myoinvasion with microcystic, elongated, and fragmented (MELF) pattern; low nuclear grade and superficial myoinvasion persisted on multivariate analysis. Features of tumors that recurred at other sites included large size, deep myoinvasion, tumor necrosis, 1 or more LVI foci, LVI foci distant/deeper than invasive tumor front, MELF myoinvasion pattern, lower uterine segment and cervical stromal involvement, pelvic and/or paraaortic lymph node metastases at presentation, and higher grade of tumor in the metastatic foci, whereas increased percentage of solid component and lower percentage of mucinous features were marginally associated. Tumors with recurrences only in vagina had different features than tumors that recurred at other sites. The presence of tumor necrosis, MELF foci at the invasive tumor front, and the percentage of solid component and mucinous features could be helpful in grading endometrioid adenocarcinomas, if a 2-tier rather than a 3-tier grading system is accepted in the future. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:1529 / 1539
页数:11
相关论文
共 50 条
  • [1] Risk Factors for Recurrence and Prognosis of Low-grade Endometrial Adenocarcinoma; Vaginal Versus Other Sites
    Moschiano, Elizabeth J.
    Barbuto, Denise A.
    Walsh, Christine
    Singh, Kanwaljit
    Euscher, Elizabeth D.
    Roma, Andres A.
    Ali-Fehmi, Rouba
    Frauenhoffer, Elizabeth E.
    Montiel, Delia P.
    Kim, Insun
    Djordjevic, Bojana
    Malpica, Anais
    Hong, Sung Ran
    Silva, Elvio G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2014, 33 (03) : 268 - 273
  • [2] Genomic biomarkers of recurrence in low-grade, early-stage endometrial adenocarcinoma.
    Hwang, Katie Lee
    Hwang, William L.
    Howitt, Brooke E.
    King, Martin T.
    Stover, Elizabeth
    Matulonis, Ursula A.
    Lee, Larissa Janeen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Risk Factors in Patients with Low-Grade Endometrial Adenocarcinoma and Lung Recurrence Versus Recurrence at Other Sites. A Multi-Institutional Study
    Roma, A. A.
    Barbuto, D. A.
    Euscher, E.
    Ali-Fehmi, R.
    Djordjevic, B.
    Bennett, J. A.
    Frauenhoffer, E. E.
    Hong, S. R.
    Kim, I.
    Montiel, D.
    Moschiano, E.
    Malpica, A.
    Silva, E. G.
    MODERN PATHOLOGY, 2013, 26 : 294A - 294A
  • [4] Risk Factors in Patients with Low-Grade Endometrial Adenocarcinoma and Lung Recurrence Versus Recurrence at Other Sites. A Multi-Institutional Study
    Roma, A. A.
    Barbuto, D. A.
    Euscher, E.
    Ali-Fehmi, R.
    Djordjevic, B.
    Bennett, J. A.
    Frauenhoffer, E. E.
    Hong, S. R.
    Kim, I.
    Montiel, D.
    Moschiano, E.
    Malpica, A.
    Silva, E. G.
    LABORATORY INVESTIGATION, 2013, 93 : 294A - 294A
  • [5] Polymorphous Low-Grade Adenocarcinoma: A Case Series and Determination of Recurrence
    Kimple, Adam J.
    Austin, Grace K.
    Shah, Rupali N.
    Welch, Chris M.
    Funkhouser, William K.
    Zanation, Adam M.
    Shockley, William W.
    LARYNGOSCOPE, 2014, 124 (12): : 2714 - 2719
  • [6] Factor analysis of risk variables associated with low-grade inflammation
    Aronson, Doron
    Avizohar, Ophir
    Jacob, Gins
    Markiewicz, Walter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A302 - A303
  • [7] Factor analysis of risk variables associated with low-grade inflammation
    Aronson, Doron
    Avizohar, Ophir
    Levy, Yishai
    Bartha, Peter
    Jacob, Giris
    Markiewicz, Walter
    ATHEROSCLEROSIS, 2008, 200 (01) : 206 - 212
  • [8] FACTOR ANALYSIS OF RISK VARIABLES ASSOCIATED WITH LOW-GRADE INFLAMMATION
    Aronson, D.
    Avizohar, O.
    Jacob, G.
    Levy, Y.
    Markiewicz, W.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 114 - 114
  • [9] Outcomes after recurrence of low-grade endometrial stromal sarcoma (LGESS)
    Miller, Kathryn
    Smith, Evan
    Sonoda, Yukio
    Mueller, Jennifer
    Alektiar, Alektiar
    Makker, Vicky
    Hensley, Martee
    Abu-Rustum, Nadeem
    Leitao, Mario
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S91 - S91
  • [10] Molecular Evaluation of Low-Grade Low-Stage Endometrial Cancer With and Without Recurrence
    Matrai, Cathleen
    Chatterjee-Paer, Sudeshna
    Motanagh, Samaneh
    Sboner, Andrea
    Gupta, Divya
    Holcomb, Kevin
    Elemento, Olivier
    Mosquera, Juan Miguel
    Ellenson, Lora
    LABORATORY INVESTIGATION, 2018, 98 : 437 - 437